Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 6/20 | 0.49 |
| ▸ | CDC25B | P30305 | 6/20 | 0.49 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.48 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.48 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.48 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.48 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.48 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.47 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.47 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.47 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.46 |
| ▸ | MTOR | P42345 | 1/20 | 0.46 |
| ▸ | TACR2 | P21452 | 1/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | NT5E | P21589 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL990409 | 1.00 | SLC6A2 (0.51) | SLC6A2PTPN1CDC25BSSTR1SSTR2 | |
| SCHEMBL2323060 | 1.00 | SLC6A2 (0.51) | SLC6A2PTPN1CDC25BSSTR1SSTR2 | |
| SCHEMBL7147911 | 1.00 | SLC6A2 (0.51) | SLC6A2PTPN1CDC25BSSTR1SSTR2 | |
| SCHEMBL7151103 | 1.00 | SLC6A2 (0.51) | SLC6A2PTPN1CDC25BSSTR1SSTR2 | |
| SCHEMBL1039870 | 1.00 | SLC6A2 (0.51) | SLC6A2PTPN1CDC25BSSTR1SSTR2 | |
| SCHEMBL23758909 | 1.00 | SLC6A2 (0.51) | SLC6A2PTPN1CDC25BSSTR1SSTR2 | |
| SCHEMBL10912453 | 1.00 | SLC6A2 (0.51) | SLC6A2PTPN1CDC25BSSTR1SSTR2 | |
| SCHEMBL18733412 | 1.00 | SLC6A2 (0.51) | SLC6A2PTPN1CDC25BSSTR1SSTR2 | |
| SCHEMBL6252622 | 1.00 | SLC6A2 (0.51) | SLC6A2PTPN1CDC25BSSTR1SSTR2 | |
| SCHEMBL30051250 | 1.00 | SLC6A2 (0.51) | SLC6A2PTPN1CDC25BSSTR1SSTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025033387-A1 | PRODUCTION METHOD FOR GLYCOLIPID DERIVATIVES, SYNTHETIC INTERMEDIATES FOR SAME, AND CRYSTALS OF SAME | ＥＡファーマ株式会社 | 2025-02-13 | — | — | WO | disclosed |
| WO-2023028338-A2 | MANNOSE 6-PHOSPHATE OR ASGPR RECEPTOR BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS | AVILAR THERAPEUTICS, INC. (US) | 2023-03-02 | — | — | WO | disclosed |
| EP-1709063-B1 | GLYCOSYLATED STEROID DERIVATIVES WITH ANTI-MIGRATORY ACTIVITY | UNIBIOSCREEN SA (BE) | 2008-01-23 | — | — | EP | disclosed |
| US-20070123473-A1 | Glycosylated steroid derivatives with anti-migratory activity | UNIBIOSCREEN S.A. (BE) | 2007-05-31 | — | — | US | disclosed |
| EP-1572715-B1 | STEROID COMPOUNDS WITH ANTI-TUMOR ACTIVITY | UNIBIOSCREEN SA (BE) | 2006-11-22 | — | — | EP | disclosed |
| EP-1709063-A2 | GLYCOSYLATED STEROID DERIVATIVES WITH ANTI-MIGRATORY ACTIVITY | Unibioscreen S.A. (BE) | 2006-10-11 | — | — | EP | disclosed |
| US-20060149045-A1 | Steroid compounds with anti-tumor activity | UNIBIOSCREEN S.A. (BE) | 2006-07-06 | — | — | US | disclosed |
| EP-1572715-A1 | STEROID COMPOUNDS WITH ANTI-TUMOR ACTIVITY | Unibioscreen S.A. (BE) | 2005-09-14 | — | — | EP | disclosed |
| WO-2005058934-A2 | GLYCOSYLATED STEROID DERIVATIVES WITH ANTI-MIGRATORY ACTIVITY | UNIBIOSCREEN S.A. (BE) | 2005-06-30 | — | — | WO | disclosed |
| WO-2004055039-A1 | STEROID COMPOUNDS WITH ANTI-TUMOR ACTIVITY | UNIBIOSCREEN S.A. (BE) | 2004-07-01 | — | — | WO | disclosed |
| EP-0984974-A1 | GLYCOCONJUGATES OF OPIATED SUBSTANCES | ROLABO S.L. (ES) | 2000-03-15 | — | — | EP | disclosed |
| WO-1998054196-A1 | GLYCOCONJUGATES OF OPIATED SUBSTANCES | ROLABO SL (ES) | 1998-12-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070123473-A1 | Glycosylated steroid derivatives with anti-migratory activity | NR5A1, NR3C2, MIF | SLC6A2 1958/4885PTPN1 1795/4885CDC25B 1701/4885 |
| US-20060149045-A1 | Steroid compounds with anti-tumor activity | CYP17A1, HSD17B7, NR5A1 | SLC6A2 4380/4885PTPN1 2871/4885CDC25B 1401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.